Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Free Cash Flow (2016 - 2025)

Mesa Laboratories' Free Cash Flow history spans 16 years, with the latest figure at $18.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 4.08% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $37.9 million, down 11.76%, while the annual FY2025 figure was $42.6 million, 2.39% up from the prior year.
  • Free Cash Flow for Q4 2025 was $18.0 million at Mesa Laboratories, up from $7.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $18.0 million in Q4 2025 and bottomed at -$3.0 million in Q2 2022.
  • The 5-year median for Free Cash Flow is $9.4 million (2023), against an average of $9.0 million.
  • The largest annual shift saw Free Cash Flow crashed 133.97% in 2022 before it surged 418.48% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at $13.8 million in 2021, then tumbled by 56.18% to $6.1 million in 2022, then soared by 71.62% to $10.4 million in 2023, then soared by 66.39% to $17.3 million in 2024, then grew by 4.08% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Free Cash Flow are $18.0 million (Q4 2025), $7.1 million (Q3 2025), and $884000.0 (Q2 2025).